Evidence map›Paper›PMID 35052948›Full record

ReviewAntibiotics (Basel, Switzerland)2022

Interventions for Early-Stage Pericoronitis: Systematic Review of Randomized Clinical Trials.

Tânia Oppido Schalch, Ana Luiza Cabrera Martimbianco, Marcela Leticia Leal Gonçalves, Lara Jansiski Motta, Elaine Marcilio Santos, Rebeca Boltes Cecatto, Sandra Kalil Bussadori, Anna Carolina Ratto Tempestini Horliana

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tânia Oppido SchalchPostgraduation Program in Biophotonics Applied to Health Sciences, Universidade Nove de Julho (UNINOVE), São Paulo 01504-000, SP, Brazil.
Ana Luiza Cabrera MartimbiancoPostgraduation Program in Health and Environment, Universidade Metropolitana de Santos (UNIMES), Santos 11045-002, SP, Brazil.ORCID 0000-0002-4361-4526
Marcela Leticia Leal GonçalvesPostgraduation Program in Health and Environment, Universidade Metropolitana de Santos (UNIMES), Santos 11045-002, SP, Brazil.
Lara Jansiski MottaPostgraduation Program in Biophotonics Applied to Health Sciences, Universidade Nove de Julho (UNINOVE), São Paulo 01504-000, SP, Brazil.ORCID 0000-0002-7774-4345
Elaine Marcilio SantosPostgraduation Program in Health and Environment, Universidade Metropolitana de Santos (UNIMES), Santos 11045-002, SP, Brazil.
Rebeca Boltes CecattoPostgraduation Program in Biophotonics Applied to Health Sciences, Universidade Nove de Julho (UNINOVE), São Paulo 01504-000, SP, Brazil.
Sandra Kalil BussadoriPostgraduation Program in Biophotonics Applied to Health Sciences, Universidade Nove de Julho (UNINOVE), São Paulo 01504-000, SP, Brazil.
Anna Carolina Ratto Tempestini HorlianaPostgraduation Program in Biophotonics Applied to Health Sciences, Universidade Nove de Julho (UNINOVE), São Paulo 01504-000, SP, Brazil.ORCID 0000-0003-3476-9064
Universidade Nove de Julho · BRUniversidade Metropolitana de Santos · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior #8887.624880/2021-00
6 · The paper itself

Abstract

backgroundTo investigate the efficacy and safety of interventions for early stage pericoronitis.

methodsWe searched for randomized controlled trials (RCTs) in databases from inception to July 2020, without language restriction. RCTs assessing adolescents and adults were included.

resultsSeven RCT with clinical diversity were included, so, it was not possible to conduct meta-analyses. Individual study data showed an improvement in oral health quality of life in favor of topical benzydamine versus diclofenac capsule (Mean difference (MD) -1.10, 95% Confidence interval (CI) -1.85 to -0.35), and no difference between topical benzydamine and flurbiprofen capsule (MD -0.55 95% CI -1.18 to 0.0). There was no difference between diclofenac and flurbiprofen capsules (MD 0.55, 95% CI -0.29 to 1.39). An imprecise estimate of effects was found for all outcomes, considering (i) oral versus topic pharmacological treatment, (ii) different oral pharmacological treatments, (iii) pharmacological treatment associated with laser versus placebo laser, (iv) pharmacological treatment associated with different mouthwashes, and (v) conventional treatment associated to antimicrobial photodynamic therapy versus conventional treatment, with low to very low certainty of evidence.

conclusionsUntil future well-designed studies can be conducted, the clinical decision for early stage pericoronitis should be guided by individual characteristics, settings and financial aspects.

Indexed as

pericoronitissystematic reviewtreatment

Identifiers

PMID35052948
PMCPMC8772688
OpenAlexW4206269440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.